121 related articles for article (PubMed ID: 8058420)
1. Protective effect of albuterol delivered via a spacer device (Babyhaler) against methacholine induced bronchoconstriction in young wheezy children.
Avital A; Godfrey S; Schachter J; Springer C
Pediatr Pulmonol; 1994 May; 17(5):281-4. PubMed ID: 8058420
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
3. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness.
Clarke JR; Aston H; Silverman M
Arch Dis Child; 1993 Jul; 69(1):125-9. PubMed ID: 8024294
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma.
Mallol J; Aguirre V; Rhem R; Rodriguez J; Dolovich M
Pediatr Pulmonol; 2001 Dec; 32(6):447-52. PubMed ID: 11747248
[TBL] [Abstract][Full Text] [Related]
5. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
6. Onset of relief of dyspnoea with budesonide/formoterol or salbutamol following methacholine-induced severe bronchoconstriction in adults with asthma: a double-blind, placebo-controlled study.
Jonkers RE; Bantje TA; Aalbers R
Respir Res; 2006 Dec; 7(1):141. PubMed ID: 17144916
[TBL] [Abstract][Full Text] [Related]
7. Dose-response protective effect of salbutamol on methacholine airway responsiveness using pressurized metered dose inhalers and Turbuhalers.
Wong AG; O'Byrne PM; Lindbladh C; Inman MD; Stâhl E; Hargreave FE
Can Respir J; 1998; 5(2):119-23. PubMed ID: 9707454
[TBL] [Abstract][Full Text] [Related]
8. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction.
Raissy HH; Harkins M; Esparham A; Kelly HW
Pharmacotherapy; 2007 Sep; 27(9):1231-6. PubMed ID: 17723076
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic equivalence of Spiros dry powder inhaler and Ventolin metered dose inhaler. A bioassay using methacholine.
Ahrens RC; Hendeles L; Clarke WR; Dockhorn RJ; Hill MR; Vaughan LM; Lux C; Han SH
Am J Respir Crit Care Med; 1999 Oct; 160(4):1238-43. PubMed ID: 10508813
[TBL] [Abstract][Full Text] [Related]
11. Salbutamol pMDI gives less protection to methacholine induced airway obstruction than salbutamol via spacer or DPI.
Broeders ME; Molema J; Hop WC; Folgering HT
Eur J Clin Pharmacol; 2005 Feb; 60(12):837-41. PubMed ID: 15625613
[TBL] [Abstract][Full Text] [Related]
12. [Agreement between tracheal auscultation and pulmonary function in methacholine bronchial inhalation challenge in asthmatic children].
de Frutos Martínez C; González Pérez-Yarza E; Aldasoro Ruiz A; Emparanza Knörr JI; Callén Blecua M; Mintegui Aramburu J
An Esp Pediatr; 2002 Apr; 56(4):304-9. PubMed ID: 11927097
[TBL] [Abstract][Full Text] [Related]
13. The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma.
Pavord I; Mudassar T; Bennett J; Wilding P; Knox A
Eur Respir J; 1996 Feb; 9(2):217-9. PubMed ID: 8777954
[TBL] [Abstract][Full Text] [Related]
14. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
15. Protection against methacholine bronchoconstriction to assess relative potency of inhaled beta2-agonist.
Parameswaran KN; Inman MD; Ekholm BP; Morris MM; Summers E; O'Byrne PM; Hargreave FE
Am J Respir Crit Care Med; 1999 Jul; 160(1):354-7. PubMed ID: 10390425
[TBL] [Abstract][Full Text] [Related]
16. Nebulizers vs metered-dose inhalers with spacers for bronchodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department.
Delgado A; Chou KJ; Silver EJ; Crain EF
Arch Pediatr Adolesc Med; 2003 Jan; 157(1):76-80. PubMed ID: 12517199
[TBL] [Abstract][Full Text] [Related]
17. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
Lipworth BJ; Aziz I
J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline.
Finnerty JP; Howarth PH
Am Rev Respir Dis; 1993 Aug; 148(2):512-3. PubMed ID: 8342917
[TBL] [Abstract][Full Text] [Related]
19. Agreement between two methods for assessing bioequivalence of inhaled salbutamol.
Lavorini F; Geri P; Camiciottoli G; Pistolesi M; Fontana GA
Pulm Pharmacol Ther; 2008; 21(2):380-4. PubMed ID: 17997115
[TBL] [Abstract][Full Text] [Related]
20. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
